Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Drug Development

      Formulation Challenges in Biosimilars Development

      Drug Development
      Overcoming Formulation Barriers in Biosimilars Development The biosimilar landscape represents one of the most dynamic and challenging frontiers in pharmaceutical development, where scientific complexity intersects...

      Enhancing Stability in Biologics Formulation

      Insights
      Enhancing Stability and Shelf Life in Biologics Formulation Biologic therapies have revolutionized treatment across diverse disease areas, yet their complex structures and sensitivity to environmental...

      FDA Approves Celltrion’s EYDENZELT for Retinal Diseases

      Americas
      Celltrion, Inc. said the U.S. Food and Drug Administration (FDA) has approved EYDENZELT® (aflibercept-boav), a biosimilar of EYLEA® (aflibercept), for several retinal conditions. These...

      FDA Clears UZEDY Injection for Bipolar I Disorder in Adults

      Americas
      The U.S. Food and Drug Administration (FDA) has approved UZEDY® (risperidone) as a once-monthly, extended-release injectable suspension for adults with bipolar I disorder (BD-I)....

      FDA Clears Elecsys pTau181 Alzheimer’s Test by Roche, Lilly

      Americas
      The US Food and Drug Administration (FDA) has approved a new blood test aimed at assessing Alzheimer’s disease and other cognitive impairments, potentially allowing...

      UK Grants Pharma Firms Early Access to Aligned Pathway

      Drug Development
      Pharmaceutical companies producing qualifying medicines can now benefit from an accelerated approvals pathway, gaining access significantly earlier than initially expected. The Medicines and Healthcare products...

      US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

      Americas
      The U.S. Food and Drug Administration (FDA) has approved Jascayd (nerandomilast) tablets to treat idiopathic pulmonary fibrosis (IPF), a rare and serious lung disease....

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

      System

      Resources

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.